ADC Therapeutics SA (NYSE:ADCT) Receives Consensus Recommendation of Hold from Brokerages

ADC Therapeutics SA (NYSE:ADCT – Get Free Report) has received a consensus rating of “Hold” from the seven analysts that are covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and three have given a buy recommendation to the company. The […]

Related Keywords

Canada , ,Therapeutics Company Profile ,Prospera Financial Services Inc ,Cubist Systematic Strategies ,Jpmorgan Chase Co ,Royal Bank ,Tower Research Capital ,Advisor Group Holdings Inc ,Get Free Report ,Marketbeat Ratings ,Group Holdings ,Research Capital ,Systematic Strategies ,Trading Down ,Get Free ,Adc Therapeutics ,Nyse Adct ,Hadct ,Medical ,Ratings ,Consensus ,